EyeGate Pharmaceuticals Funding: $31M Raised, Series C
EyeGate Pharmaceuticals is based in Waltham, MA. It has raised $31M in total funding. Latest round: Series C.
EyeGate Pharmaceuticals funding overview
EyeGate Pharmaceuticals is based in Waltham, MA. EyeGate Pharmaceuticals has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2008. The round record for EyeGate Pharmaceuticals runs through 2008; nothing later has been disclosed. Investors on record include Medicis Capital, Ventech, Innoven Partenaires, The Nexus Group. 4 distinct backers are named across the disclosed rounds.
EyeGate Pharmaceuticals at a glance
Total raised
$31M
Latest round
Series C
Latest round date
March 2008
Headquarters
Waltham, MA
Notable investors
Medicis Capital, Ventech, Innoven Partenaires, The Nexus Group
Frequently asked about EyeGate Pharmaceuticals funding
How much has EyeGate Pharmaceuticals raised?
EyeGate Pharmaceuticals has raised $31M in total disclosed funding across the rounds on record.
Who has invested in EyeGate Pharmaceuticals?
Medicis Capital, Ventech, Innoven Partenaires, The Nexus Group are named among the investors backing EyeGate Pharmaceuticals.
What was the latest EyeGate Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in March 2008.
Where is EyeGate Pharmaceuticals based?
EyeGate Pharmaceuticals is based in Waltham, MA.
When did EyeGate Pharmaceuticals last raise?
The last disclosed EyeGate Pharmaceuticals round closed in March 2008 at Series C.
Every EyeGate Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Waltham at a similar stage.
